{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:51:57Z","timestamp":1753275117498},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:p>This cross-sectional study examines how list prices for indomethacin have changed since 2019 and characterizes variation in hospital charges for the drug, including gross charges and discounted cash prices.<\/jats:p>","DOI":"10.1001\/jamanetworkopen.2024.35528","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T15:57:32Z","timestamp":1727366252000},"page":"e2435528","source":"Crossref","is-referenced-by-count":1,"title":["Price and Variability in Hospital Charges for Generic Indomethacin Suppositories"],"prefix":"10.1001","volume":"7","author":[{"given":"Noah M.","family":"Feder","sequence":"first","affiliation":[{"name":"Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Hernandez","sequence":"additional","affiliation":[{"name":"UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathavan","family":"Murali","sequence":"additional","affiliation":[{"name":"Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[{"name":"Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Joseph","family":"Elmunzer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid F.","family":"Gellad","sequence":"additional","affiliation":[{"name":"Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"issue":"15","key":"zld240159r1","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.","volume":"366","author":"Elmunzer","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"zld240159r2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jamainternmed.2020.0099","article-title":"The skyrocketing cost of rectal indomethacin.","volume":"180","author":"Elmunzer","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zld240159r3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.gie.2019.09.008","article-title":"Indomethacin for post-ERCP pancreatitis: Prophylaxis at what cost?","volume":"91","author":"Storm","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"zld240159r6","year":"2023"},{"key":"zld240159r4","unstructured":"Office of the Inspector General. OIG policy statement regarding hospitals that discount or waive amounts owed by Medicare beneficiaries for self-administered drugs dispensed in outpatient settings. Accessed August 21, 2024. https:\/\/oig.hhs.gov\/compliance\/alerts\/guidance\/policy-10302015.pdf"},{"key":"zld240159r5","unstructured":"Centers for Medicare and Medicaid Services. Hospital Provider Cost Report. Accessed July 1, 2023. https:\/\/data.cms.gov\/provider-compliance\/cost-report\/hospital-provider-cost-report\/data"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2824107\/feder_2024_ld_240159_1726754318.35484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T15:57:34Z","timestamp":1727366254000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2824107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.35528","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}